ZA945045B - Derivatives of imidazo (1,2-a) pyrazin-4-one their preparation and medicaments containing them - Google Patents
Derivatives of imidazo (1,2-a) pyrazin-4-one their preparation and medicaments containing themInfo
- Publication number
- ZA945045B ZA945045B ZA945045A ZA945045A ZA945045B ZA 945045 B ZA945045 B ZA 945045B ZA 945045 A ZA945045 A ZA 945045A ZA 945045 A ZA945045 A ZA 945045A ZA 945045 B ZA945045 B ZA 945045B
- Authority
- ZA
- South Africa
- Prior art keywords
- alk
- alkyl
- het
- phenyl
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9308754A FR2707643B1 (fr) | 1993-07-16 | 1993-07-16 | Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA945045B true ZA945045B (en) | 1995-02-22 |
Family
ID=9449312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA945045A ZA945045B (en) | 1993-07-16 | 1994-07-12 | Derivatives of imidazo (1,2-a) pyrazin-4-one their preparation and medicaments containing them |
Country Status (18)
Country | Link |
---|---|
US (1) | US5753657A (no) |
EP (1) | EP0708774B1 (no) |
JP (1) | JPH09500873A (no) |
AT (1) | ATE177746T1 (no) |
AU (1) | AU681688B2 (no) |
CA (1) | CA2167169A1 (no) |
DE (1) | DE69417235T2 (no) |
DK (1) | DK0708774T3 (no) |
ES (1) | ES2130438T3 (no) |
FI (1) | FI960160A (no) |
FR (1) | FR2707643B1 (no) |
GR (1) | GR3029713T3 (no) |
HU (1) | HUT74678A (no) |
IL (1) | IL110329A0 (no) |
NO (1) | NO955192L (no) |
PL (1) | PL312571A1 (no) |
WO (1) | WO1995002601A1 (no) |
ZA (1) | ZA945045B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2717813B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Dérivés d'imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant . |
FR2717805B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Dérivés de 5H-indeno[1,2-b]pyrazine-2,3-dione, leur préparation et les médicaments les contenant . |
FR2717812B1 (fr) * | 1994-03-28 | 1996-05-10 | Rhone Poulenc Rorer Sa | Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant. |
FR2726275B1 (fr) * | 1994-11-02 | 1996-12-06 | Rhone Poulenc Rorer Sa | Spiro heterocycle-imidazo(1,2-a)indeno(1,2-e)pyrazine)-4'- ones, leur preparation et les medicaments les contenants |
FR2738821B1 (fr) * | 1995-09-15 | 1997-11-21 | Rhone Poulenc Rorer Sa | Indeno[1,2-e]pyrazin-4-ones, leur preparation et les medicaments les contenant |
EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
AU2007315885B2 (en) * | 2006-10-30 | 2013-01-31 | Hybrigenics Sa | Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
EP2170334B1 (en) * | 2007-06-29 | 2021-03-17 | Emory University | Nmda receptor antagonists for neuroprotection |
KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2789440C (en) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9049391A (en) * | 1990-12-20 | 1992-07-22 | Warner-Lambert Company | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity |
US5196421A (en) | 1991-06-05 | 1993-03-23 | Eli Lilly And Company | Excitatory amino acid receptor antagonists in methods for the use thereof |
US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
FR2696466B1 (fr) * | 1992-10-02 | 1994-11-25 | Rhone Poulenc Rorer Sa | Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant. |
-
1993
- 1993-07-16 FR FR9308754A patent/FR2707643B1/fr not_active Expired - Fee Related
-
1994
- 1994-07-11 HU HU9503955A patent/HUT74678A/hu unknown
- 1994-07-11 WO PCT/FR1994/000866 patent/WO1995002601A1/fr active IP Right Grant
- 1994-07-11 CA CA002167169A patent/CA2167169A1/fr not_active Abandoned
- 1994-07-11 EP EP94922904A patent/EP0708774B1/fr not_active Expired - Lifetime
- 1994-07-11 AU AU72652/94A patent/AU681688B2/en not_active Withdrawn - After Issue
- 1994-07-11 US US08/583,126 patent/US5753657A/en not_active Expired - Fee Related
- 1994-07-11 AT AT94922904T patent/ATE177746T1/de not_active IP Right Cessation
- 1994-07-11 JP JP7504376A patent/JPH09500873A/ja active Pending
- 1994-07-11 PL PL94312571A patent/PL312571A1/xx unknown
- 1994-07-11 ES ES94922904T patent/ES2130438T3/es not_active Expired - Lifetime
- 1994-07-11 DE DE69417235T patent/DE69417235T2/de not_active Expired - Fee Related
- 1994-07-11 DK DK94922904T patent/DK0708774T3/da active
- 1994-07-12 ZA ZA945045A patent/ZA945045B/xx unknown
- 1994-07-14 IL IL11032994A patent/IL110329A0/xx unknown
-
1995
- 1995-12-20 NO NO955192A patent/NO955192L/no unknown
-
1996
- 1996-01-12 FI FI960160A patent/FI960160A/fi not_active Application Discontinuation
-
1999
- 1999-03-18 GR GR980402654T patent/GR3029713T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO955192D0 (no) | 1995-12-20 |
PL312571A1 (en) | 1996-04-29 |
EP0708774A1 (fr) | 1996-05-01 |
DE69417235D1 (de) | 1999-04-22 |
FR2707643B1 (fr) | 1995-08-11 |
ATE177746T1 (de) | 1999-04-15 |
HU9503955D0 (en) | 1996-03-28 |
NO955192L (no) | 1995-12-20 |
ES2130438T3 (es) | 1999-07-01 |
HUT74678A (en) | 1997-01-28 |
FR2707643A1 (fr) | 1995-01-20 |
FI960160A0 (fi) | 1996-01-12 |
DE69417235T2 (de) | 1999-07-08 |
AU681688B2 (en) | 1997-09-04 |
GR3029713T3 (en) | 1999-06-30 |
IL110329A0 (en) | 1994-10-21 |
AU7265294A (en) | 1995-02-13 |
JPH09500873A (ja) | 1997-01-28 |
WO1995002601A1 (fr) | 1995-01-26 |
DK0708774T3 (da) | 1999-10-11 |
EP0708774B1 (fr) | 1999-03-17 |
US5753657A (en) | 1998-05-19 |
FI960160A (fi) | 1996-01-12 |
CA2167169A1 (fr) | 1995-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA945045B (en) | Derivatives of imidazo (1,2-a) pyrazin-4-one their preparation and medicaments containing them | |
GR3022498T3 (en) | Imidazo[1,2-a]pyrazin-4-one derivatives for use as ampa and nmda receptor antagonists | |
GR3030274T3 (en) | 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME | |
CA2244777A1 (en) | 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors | |
HK1009043A1 (en) | Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase | |
FI951555A0 (fi) | 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet | |
DE69509888T2 (de) | IMIDAZO[1,2-a]INDENO [1,2-e] PYRAZINONE ANTAGONISTEN DER AMPA UND NMDA REZEPTOREN | |
IL113148A0 (en) | Imidazo [1,2-a] - indeno [1,2-e]pyrazin-4-one derivatives and preparation thereof | |
ATE225335T1 (de) | Amide derivate als 5-ht1a liganden | |
ES479110A1 (es) | Procedimiento para preparar derivados de benzamidina. | |
ES2009463A6 (es) | Procedimiento de preparacion de derivados de 2-propanol. |